fludarabine has been researched along with Lupus Nephritis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, PJ; Feliz, A; Gok, F; Good, RA; Jones, JM; Jones, OY; Lacson, A; Madivi, C; Marikar, Y | 1 |
| Austin, HA; Balow, JE; Boumpas, DT; Chitkara, P; Fleisher, T; Illei, GG; Klippel, JH; Kuroiwa, T; Schlimgen, R; Tisdale, JF; Yarboro, CH | 1 |
| Austin, HA; Balow, JE; Boumpas, DT; Fleisher, TA; Kim, Y; Piscitelli, S; Pucino, F; Tassiulas, IO; Vaughan, E | 1 |
| Boumpas, DT; Burstein, AH; Illei, GG; Kuo, GM; Pucino, F; Yarboro, C | 1 |
| de Frutos, MA | 1 |
2 trial(s) available for fludarabine and Lupus Nephritis
| Article | Year |
|---|---|
Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis.
Topics: Adult; Aged; CD4 Lymphocyte Count; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Lymphopenia; Male; Middle Aged; Neutropenia; Pilot Projects; Proteinuria; Treatment Outcome; Vidarabine | 2007 |
Fludarabine pharmacokinetics after subcutaneous and intravenous administration in patients with lupus nephritis.
Topics: Adult; Antineoplastic Agents; Confidence Intervals; Cross-Over Studies; Cyclophosphamide; Female; Humans; Infusions, Intravenous; Injections, Subcutaneous; Lupus Nephritis; Male; Middle Aged; Statistics, Nonparametric; Vidarabine | 2001 |
3 other study(ies) available for fludarabine and Lupus Nephritis
| Article | Year |
|---|---|
Effects of fludarabine treatment on murine lupus nephritis.
Topics: Animals; Cyclophosphamide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Immunosuppressive Agents; Kidney Glomerulus; Lupus Nephritis; Lymphocyte Count; Male; Mice; Spleen; Vidarabine | 2004 |
A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
Topics: Adult; Alkylating Agents; Anti-Inflammatory Agents; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Humans; Immunoglobulin G; Immunologic Memory; Immunosuppressive Agents; Lupus Nephritis; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Pilot Projects; Prednisone; Proteinuria; Renal Plasma Flow, Effective; Sinusitis; Vidarabine | 1999 |
[Lupus nephritis: treatments for today and tomorrow].
Topics: Adrenal Cortex Hormones; Animals; Antibodies, Monoclonal; Bone Marrow Transplantation; CD40 Ligand; Cladribine; Drug Administration Schedule; Drug Therapy, Combination; Forecasting; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Oligonucleotides; Plasmapheresis; Vidarabine | 2001 |